Acute Respiratory Distress Syndrome

Children Not Immune to Coronavirus; New Study from Pandemic Epicenter Describes Severe COVID-19 Response in Children

May 19, 2020 sarah Jonas Acute Respiratory Distress Syndrome, Children, Coronavirus, COVID-19, Hospitalization, Infectious Desease, Inflammation, Intensive Care, Pandemic, Pediatrics

While most children infected with the novel coronavirus have mild symptoms, a subset requires hospitalization and a small number require intensive care. A new report from pediatric anesthesiologists, infectious disease specialists and pediatricians at the Children’s Hospital at Montefiore (CHAM) and Albert Einstein College of Medicine, describes the clinical characteristics and outcomes of children hospitalized with COVID-19, during the early days of the pandemic.

Feature

COVID-19 and the Challenging Acute Respiratory Distress Syndrome (ARDS)

May 5, 2020 sarah Jonas Acute Respiratory Distress Syndrome, anti-inflammatory, Antibodies, Coronavirus, COVID-19, ICU, ICU Care, Intensive Care, Lungs, respirators, Treatments, Ventilation

Joe G. N. “Skip” Garcia, MD, an academic pulmonary physician-scientist describes a complication in COVID-19.

Feature

First COVID-19 patient in Texas enrolled in UTHealth stem cell therapy study at Memorial Hermann

April 17, 2020 sarah Jonas Acute Respiratory Distress Syndrome, ARDS, COVID-19, Stem Cell Therapy, The University of Texas Health Science at Houston (UTHealth)

The first COVID-19 patient in Texas has been enrolled in a stem cell therapy clinical trial for acute respiratory distress syndrome (ARDS) at The University of Texas Health Science Center at Houston (UTHealth).

Research Results

BIDMC launches clinical trial to assess common anti-clotting medication for treatment of COVID-19-related respiratory failure

April 6, 2020 sarah Jonas Acute Respiratory Distress Syndrome, Coronavirus, COVID-19

A team of physician-scientists at Beth Israel Deaconess Medical Center are now enrolling patients in a clinical trial to evaluate a common anti-clotting drug for the treatment of COVID-19-positive patients with ARDS. The newly launched trial follows a special report the team published in the Journal of Trauma and Acute Care Surgery that suggested the use of a drug called tPA could reduce deaths among patients with ARDS as a complication of COVID-19.

Research Results

Lung Microbiome May Help Predict Outcomes in Critically Ill Patients

January 21, 2020 sarah Jonas 0 Comments Acute Respiratory Distress Syndrome, Critical Care Medicine

Changes in the lung microbiome may help predict how well critically ill patients will respond to care, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.